GC Genome made a foray into the global bussiness in earnest, Middle East/Asia, etc.

GC Genome presented AI-Based Liquid Biopsy at the American Association for Cancer Research (AACR) Annual Meeting 2022

Approval of GC Genome's New Heath Technology, 'GreenPlan HRD'

GC Genome Signed a supply contraction with Korea Association of Health Promotion 'Greenbiome PERIO&DENTI' test.

GC Genome participated at 'Medlab Middle East 2022', succeeded with the first step in the Middle East market

GC Genome & GC Well-being published in international journal... 'Osteoarthritis improvement effect of GCWB 106' thesis

GC Genome selected as Top 10 'Frontier company' who leads global market entry

GC Genome has signed a MOU for strategic partnership with TPG from Thailand

Chang-Seok Ki, CEO of GC Genome, received a plaque of appreciation from Korea Rare Disease Foundation

GC Genome presented on the topic of 'multi cancer diagnosis through liquid biopsy'